data13F

DRUG – Bright Minds Biosciences Inc

Held by 1 of 60 tracked investors in their latest 13F filing · 0 counted on Most owned (narrow-view filings excluded)

Investors holding1
Combined shares8,241
Combined reported value$411K

DRUG chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.

Ownership

Investor% of their portfolioChangeSharesReported valuePeriod
Paul Tudor Jones narrow view 0.00 Reduced 0.6%8,241$411KQ3 2026

Activity: last 4 quarters

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Paul Tudor Jones narrow view Reduced 0.6%8,2410.00
Q2 2026Paul Tudor Jones narrow view New8,2910.00

Added: opened or increased

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q2 2026Paul Tudor Jones narrow view New8,2910.00

Reduced: reduced or closed

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Paul Tudor Jones narrow view Reduced 0.6%8,2410.00

History

1 peakQ3 2026: 1 tracked investors
Q2 2026: 1 tracked investorsQ3 2026: 1 tracked investors
20262026
Tracked investors reporting this stock, by quarter

Shares held, last 8 quarters

InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Paul Tudor Jones8.2K8.3K––––––

– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).